Document Detail

Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.
MedLine Citation:
PMID:  7977086     Owner:  NLM     Status:  MEDLINE    
Prospective evaluations of intravenous lidocaine as therapy for sustained monomorphic ventricular tachycardia (VT) in the absence of acute myocardial infarction are lacking. Lidocaine has been promulgated as first-line therapy in patients with VT, but studies evaluating its efficacy in the electrophysiology laboratory suggest that it has poor effects in terminating or preventing induction of VT. Thus, this study sought to evaluate the clinical effectiveness of lidocaine in 3 cohorts with induced or spontaneous VT. One hundred twenty-eight patients with stable VT, occurring either spontaneously or induced at the time of electrophysiologic study either in the baseline state or at the time of pharmacologic testing, were evaluated. The response rate to lidocaine therapy as manifested by termination of VT was the primary goal of the study. Of these patients, 10 (8%) had termination of VT after lidocaine therapy. There were no significant differences in age, ejection fraction, VT cycle length, and mean dose of lidocaine between responders and 118 nonresponders. There were no serious side effects or adverse events (death, myocardial infarction, angina, or congestive heart failure). Lidocaine, although safe, is ineffective in terminating stable VT not associated with acute myocardial infarction.
N Nasir; A Taylor; T K Doyle; A Pacifico
Related Documents :
17338766 - Obesity as a risk factor for sustained ventricular tachyarrhythmias in madit ii patients.
20946226 - Temporal associations between thoracic volume overload and malignant ventricular arrhyt...
17946766 - Spontaneous heart rate turbulence in patients with dilated cardiomyopathy.
8443906 - Signal-averaged electrocardiogram. improved identification of patients with ventricular...
2355276 - Cardiac assistance by atrial or ventricular cardiomyoplasty.
24523766 - Resveratrol provides cardioprotection after ischemia/reperfusion injury via modulation ...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  74     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1994-12-27     Completed Date:  1994-12-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1183-6     Citation Subset:  AIM; IM    
Cardiac Electrophysiology Unit, Methodist Hospital, Houston, Texas 77030.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Coronary Disease / complications*
Electric Stimulation
Injections, Intravenous
Lidocaine / therapeutic use*
Middle Aged
Myocardial Infarction / complications*
Tachycardia, Ventricular / drug therapy*,  etiology
Treatment Outcome
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Frequency of left atrioventricular regurgitation postoperatively after repair of complete atrioventr...
Next Document:  Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aorto...